---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-057807"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:24:06.914182+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aprea Therapeutics stockholders elect director slate, ratify auditor, approve say-on-pay at 2025 annual meeting

## Summary
- All three Class III directors (Jean-Pierre Bizzari, Oren Gilad, John B. Henneman III) elected with >95% of votes cast for.
- Ratification of EisnerAmper LLP as 2025 auditor passed with 2,916,782 for, 49,535 against, 35,669 abstain.
- Non-binding advisory vote on exec compensation approved (1,628,716 for, 58,828 against, 34,829 abstain).
- Say-on-frequency vote: 1 year received 1,159,068 votes; plurality for 1-year frequency.
- Quorum achieved with 3,817,718 shares (69% of shares entitled to vote) represented.

## SEC filing metadata
- accession: 0001104659-25-057807
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465925057807/0001104659-25-057807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465925057807/tm2517510d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-057807
- JSON: https://secwatch.observer/filing/0001104659-25-057807.json
- Plain text: https://secwatch.observer/filing/0001104659-25-057807.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.